BTBD7 Antikörper (AA 1050-1150)
-
- Target Alle BTBD7 Produkte
- BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))
-
Bindungsspezifität
- AA 1050-1150
-
Reaktivität
- Maus, Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BTBD7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Confocal Microscopy (CM), Immunocytochemistry (ICC), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (IHC)
- Aufreinigung
- Affinity Purified
- Immunogen
- Synthetic peptide taken within amino acid region 1050-1150 on human BTBD7 protein.
- Isotyp
- IgG
-
anti-BTB (POZ) Domain Containing 7 (BTBD7) (N-Term) antibody
Verified BTBD7 Reaktivität: Maus WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-BTB (POZ) Domain Containing 7 (BTBD7) (AA 41-130) antibodyBTBD7 Reaktivität: Human, Ratte ELISA, IHC (p), FACS, IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-BTB (POZ) Domain Containing 7 (BTBD7) (N-Term) antibodyBTBD7 Reaktivität: Maus, Human, Ratte, Rind (Kuh), Hund, Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio), Saccharomyces cerevisiae WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.61-0.68 μg/μL
-
- Target
- BTBD7 (BTB (POZ) Domain Containing 7 (BTBD7))
- Andere Bezeichnung
- BTB/POZ Domain-Containing Protein 7 (BTBD7 Produkte)
- NCBI Accession
- NP_001002860
- UniProt
- Q9P203
-
